相关实验视频
Updated: Jun 17, 2025

08:50
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
538
患有中间弧形带压缩的患者的耐火十二指肠:治疗挑战
Sérgio Manuel Tubal Bronze1,2, Daniel Conceição3, Milena Mendes4
1Serviço de Gastrenterologia e Hepatologia, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.
ACG case reports journal
|August 7, 2024
概括
本案例报告强调了一种新的方法来治疗严重的上部胃肠道出血. 动脉栓塞,在干支架支架以克服中间弧形带压缩后,成功治疗了耐火十二指肠出血.
科学领域:
- 胃肠病学 胃肠病学
- 干预性放射学 干预性放射学
- 血管外科 血管外科
背景情况:
- 灵活的食管胃管腺镜是急性上部胃肠道出血的标准.
- 来自十二指肠的耐火性出血带来了重大管理挑战.
- 中间弧形带综合征可以阻碍标准的干预程序.
研究的目的:
- 提出一个成功的动脉栓塞的案例,用于耐火十二指肠出血.
- 描述使用乳干支架支架来克服解剖障碍的使用.
- 强调动脉栓塞作为一种可行的选择,用于非的上部胃肠道出血.
主要方法:
- 一名患有由于十二指球难以接受内镜治疗而导致的黑色素和低血压的患者接受了治疗.
- 由于中枢弧形带压缩干,初步试图进行胃腺动脉栓塞并未成功.
- 一个气球可扩展的支架被部署在腹膜干,使得成功的动脉栓塞.
主要成果:
- 血动脉的成功栓塞是在乳干支架后实现的.
- 患者的出血得到控制,溶解了黑色素和稳定了血液动力学.
- 这种方法促进了以前不可能的干预程序.
结论:
- 动脉栓塞是急性不变形上部胃肠道出血不响应内镜治疗的关键治疗选择.
- 乳干支架支架可以是一个有效的策略,以管理在栓塞期间的解剖挑战.
- 这个案例展示了成功的多学科方法来解决复杂的出血情景.
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
102
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
102
Peptic Ulcer Disease IV: Management
79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79
Peptic Ulcer Disease V: Surgical Management and Nursing Care
264
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
264
Peptic Ulcer Disease I: Introduction
162
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
162
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
362
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
362
Peptic Ulcer Disease II: Pathophysiology
342
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
342

